CONMED (CNMD) vs Enovis (ENOV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
CONMED (CNMD) has outperformed Enovis (ENOV) over the past year, losing 3.0% versus a loss of 45.2%. Over five years, CNMD leads with a -68.2% price change compared with -80.0% for ENOV. CONMED is the larger company by market cap ($1.33 billion vs $1.02 billion), about 1.3 times the size.
On valuation, Enovis trades at a lower forward P/E (4.9x vs 9.3x for CONMED). CONMED pays a dividend yielding 0.45%, while Enovis does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | ENOV |
|---|---|---|
| Share price | $44.42 | $17.69 |
| Market cap | $1.33B | $1.02B |
| 1-day change | -1.53% | +1.49% |
| YTD return | +11.11% | -34.57% |
| 1-year return | -3.03% | -45.15% |
| 5-year return | -68.24% | -79.99% |
| P/E ratio (TTM) | 24.01 | — |
| Forward P/E | 9.29 | 4.93 |
| EPS (TTM) | $1.85 | $-19.23 |
| Dividend yield | 0.45% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| 52-week high | $53.66 | $34.28 |
| 52-week low | $31.44 | $16.70 |
| Distance from 52-week high | -17.22% | -48.40% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +2.43% | +112.44% |
| Average volume | 482.58K | 1.46M |
| Shares outstanding | 29.95M | 57.67M |
| Employees | 3,900 | 7,802 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CNMD has outperformed ENOV by 42.1 percentage points over the past year.
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,900 employees
About Enovis
ENOV stock →Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Health Care · Industrial Specialties · 7,802 employees
CNMD vs ENOV FAQ
Which is bigger, CONMED or Enovis?
CONMED (CNMD) is larger, with a market capitalization of $1.33B compared with $1.02B for Enovis (ENOV).
Which stock has performed better over the past year, CNMD or ENOV?
CNMD returned -3.03% over the past 12 months, compared with -45.15% for ENOV (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, CONMED or Enovis?
CONMED pays a dividend yielding 0.45%, while Enovis does not currently pay a regular dividend.
Are CONMED and Enovis in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for CONMED and Industrial Specialties for Enovis.